MS Newbies: Recently Approved and Pipeline Drugs for the Treatment of Multiple Sclerosis
Learn about the newest FDA-approved Multiple Sclerosis treatment agents, their efficacy, safety features, and critical drug/patient characteristics for appropriate treatment selection.
About this course
The field of Multiple Sclerosis is ever-changing, with new targets and biomarkers being discovered each year. It can be challenging to stay up to date on newly approved agents given so many different components that play a role in treatment of Multiple Sclerosis. This activity will review the newest FDA-approved Multiple Sclerosis treatment agents including efficacy and safety features. This activity will also provide clinicians with drug/patient characteristics that are critical for appropriate treatment selection and recommendations.
Course Accreditation
This course is approved for the following professions. You can get more details on each profession by clicking on it.
Faculty
InstructorsYou might also be interested in
What are others saying?
Take a look at what other healthcare professionals are saying about AchieveCE’s continuing education courses.
Requirements
Participants must score a passing grade of 70% or higher on the activity post-test and complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CE Broker if your license information is entered properly in your profile.
- Windows 8.1
- Windows 10
- Mac OS X 10.1+
- iOS 10+
- Android 4.3+
- Google Chrome
- Microsft Edge
- Mozilla Firefox
- Adobe Acrobat Reader
- Broadband Internet Connection: T1
- Hi-speed DSL or Cable4G cellular connection